A genetic variant in microRNA target site of TGF-β signaling pathway increases the risk of colorectal cancer in a Chinese population

Tumor Biology

Volumn 35, Issue 5, 2014, Pages 4301-4306

  Gong, Jing ^a,b   Shen, Na ^a,b   Zhang, Hong Mei ^b   Zhong, Rong ^a,b   Chen, Wei ^a,b   Miao, Xiaoping ^a,b   Guo, An Yuan ^b  

^a Huazhong University of Science and Technology   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

ACVR1; Colorectal cancer; miRNA target site; Single nucleotide polymorphism

Indexed keywords

BONE MORPHOGENETIC PROTEIN 6; MICRORNA; MICRORNA 150; MICRORNA 330 3P; MICRORNA 584; MICRORNA 629; SMAD5 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; ACTIVIN RECEPTOR 1; ACVR1 PROTEIN, HUMAN;

ADULT; ARTICLE; CANCER GROWTH; CANCER RISK; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CHINESE; COLON CARCINOGENESIS; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; AGED; COLORECTAL TUMOR; GENETICS; MIDDLE AGED; PHYSIOLOGY;

ACTIVIN RECEPTORS, TYPE I; ADULT; AGED; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; FEMALE; HUMANS; MALE; MICRORNAS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 84902979951     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-013-1562-9     Document Type: Article

References (35)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69-90.
2. Chen W, Zheng R, Zhang S, Zhao P, Li G, Wu L, et al. Report of incidence and mortality in China cancer registries, 2009. Chin J Cancer Res. 2013;25:10-21.
3. Le Marchand L, Wilkens LR, Kolonel LN, Hankin JH, Lyu LC. Associations of sedentary lifestyle, obesity, smoking, alcohol use, and diabetes with the risk of colorectal cancer. Cancer Res. 1997;57:4787-94. (Pubitemid 27468985)
4. Limsui D, Limburg PJ. Cigarette smoking and colorectal cancer risk: a burning issue. Gastroenterology. 2008;135:704-5.
5. Peng XE, Jiang YY, Shi XS, Hu ZJ. Nqo1 609C>T polymorphism interaction with tobacco smoking and alcohol drinking increases colorectal cancer risk in a Chinese population. Gene. 2013;521:105-10.
6. Zhong R, Liu L, Zou L, Sheng W, Zhu B, Xiang H, et al. Genetic variations in the tgfbeta signaling pathway, smoking and risk of colorectal cancer in a chinese population. Carcinogenesis. 2013;34:936-42.
7. Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, Koskenvuo M, et al. Environmental and heritable factors in the causation of cancer - analyses of cohorts of twins from Sweden, Denmark, and Finland. New Engl J Med. 2000;343:78-85. (Pubitemid 30451850)
8. Tenesa A, Dunlop MG. New insights into the aetiology of colorectal cancer from genome-wide association studies. Nature Rev Genet. 2009;10:353-8.
9. Yang Y, Wang F, Shi C, Zou Y, Qin H, Ma Y. Cyclin d1 g870a polymorphism contributes to colorectal cancer susceptibility: evidence from a systematic review of 22 case-control studies. PloS One. 2012;7:e36813.
10. Crea F, Fornaro L, Paolicchi E, Masi G, Frumento P, Loupakis F, et al. An EZH2 polymorphism is associated with clinical outcome in metastatic colorectal cancer patients. Annals Oncol. 2012;23:1207-13.
11. Castro FA, Forsti A, Buch S, Kalthoff H, Krauss C, Bauer M, et al. Tlr-3 polymorphism is an independent prognostic marker for stage II colorectal cancer. Eur J Cancer. 2011;47:1203-10.
12. Houlston RS, Webb E, Broderick P, Pittman AM, Di Bernardo MC, Lubbe S, et al. Meta-analysis of genome-wide association data identifies four new susceptibility loci for colorectal cancer. Nature Genet. 2008;40:1426-35.
13. Akhurst RJ. TGF beta signaling in health and disease. Nature Genet. 2004;36:790-2. (Pubitemid 39014092)
14. Elliott RL, Blobe GC. Role of transforming growth factor beta in human cancer. J Clin Oncol. 2005;23:2078-93. (Pubitemid 46211385)
15. Roberts AB, Wakefield LM. The two faces of transforming growth factor beta in carcinogenesis. Proc Natl Acad Sci U S A. 2003;100:8621-3. (Pubitemid 36899145)
16. Bierie B, Moses HL. Tumour microenvironment: TGF beta: the molecular Jekyll and Hyde of cancer. Nature Rev Cancer. 2006;6:506-20. (Pubitemid 43980540)
17. Ku JL, Park SH, Yoon KA, Shin YK, Kim KH, Choi JS, et al.Genetic alterations of the TGF-beta signaling pathway in colorectal cancer cell lines: a novel mutation in SMAD3 associated with the inactivation of TGF-beta-induced transcriptional activation. Cancer Lett. 2007;247:283-92.
18. Xu Y, Pasche B. Tgf-beta signaling alterations and susceptibility to colorectal cancer. Human molecular genetics 2007;16 Spec No 1:R14-20 (Pubitemid 47241839)
19. Fukushima T, Mashiko M, Takita K, Otake T, Endo Y, Sekikawa K, et al. Mutational analysis of tgf-beta type ii receptor, smad2, smad3, smad4, smad6 and smad7 genes in colorectal cancer. J Exp Clin Cancer Res. 2003;22:315-20. (Pubitemid 36734191)
20. Bartel DP. MicrorNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116:281-97.
21. Bartel DP. MicrorNAs: target recognition and regulatory functions. Cell. 2009;136:215-33.
22. Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell. 2005;120:15-20. (Pubitemid 40094598)
23. Wang G, van der Walt JM, Mayhew G, Li YJ, Zuchner S, Scott WK, et al. Variation in the miRNA-433 binding site of FGF20 confers risk for Parkinson disease by overexpression of alpha-synuclein. Am J Human Genet. 2008;82:283-9.
24. Smits KM, Paranjape T, Nallur S, Wouters KA, Weijenberg MP, Schouten LJ, et al. A let-7 microRNA SNP in the KRAS 3'UTR is prognostic in early-stage colorectal cancer. Clinical Cancer Res. 2011;17:7723-31.
25. Sethupathy P, Borel C, Gagnebin M, Grant GR, Deutsch S, Elton TS, et al. Human microRNA-155 on chromosome 21 differentially interacts with its polymorphic target in the AGTR1 3' untranslated region: a mechanism for functional single-nucleotide polymorphisms related to phenotypes. Am J Human Genet. 2007;81:405-13. (Pubitemid 47236088)
26. Gong J, Tong Y, Zhang HM, Wang K, Hu T, Shan G, et al. Genomewide identification of SNPs in microRNA genes and the SNP effects on microRNA target binding and biogenesis. Hum Mutat. 2012;33:254-63.
27. Renlund N, O'Neill FH, Zhang L, Sidis Y, Teixeira J. Activin receptor-like kinase-2 inhibits activin signaling by blocking the binding of activin to its type II receptor. J Endocrinol. 2007;195:95-103. (Pubitemid 350056003)
28. Wu TC, Jih MH, Wang L, Wan YJ. Expression of activin receptor II and IIB mRNA isoforms in mouse reproductive organs and oocytes. Mol Reprod Dev. 1994;38:9-15. (Pubitemid 24139851)
29. Donaldson CJ, Mathews LS, Vale WW. Molecular cloning and binding properties of the human type II activin receptor. Biochem Biophys Res Comm. 1992;184:310-6.
30. Eresen Yazicioglu C, Karatosun V, Kizildag S, Ozsoylu D, Kavukcu S. Acvr1 Gene mutations in four Turkish patients diagnosed as fibrodysplasia ossificans progressiva. Gene. 2013;515:444-6.
31. Shore EM, Xu M, Feldman GJ, Fenstermacher DA, Cho TJ, Choi IH, et al. A recurrent mutation in the bmp type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva. Nature Genet. 2006;38:525-7.
32. Ambrosio EP, Drigo SA, Bergamo NA, Rosa FE, Bertonha FB, de Abreu FB, et al. Recurrent copy number gains of ACVR1 and corresponding transcript overexpression are associated with survival in head and neck squamous cell carcinomas. Histopathology. 2011;59:81-9.
33. Wiley LA, Rajagopal R, Dattilo LK, Beebe DC. The tumor suppressor gene TRP53 protects themouse lens against posterior subcapsular cataracts and the bmp receptor ACVR1 acts as a tumor suppressor in the lens. Disease Models Mech. 2011;4:484-95.
34. Nicoloso MS, Sun H, Spizzo R, Kim H, Wickramasinghe P, Shimizu M, et al. Single-nucleotide polymorphisms inside microRNA target sites influence tumor susceptibility. Cancer Res. 2010;70:2789-98.
35. Zhao X, Ye Q, Xu K, Cheng J, Gao Y, Li Q, et al. Single-nucleotide polymorphisms inside microrna target sites influence the susceptibility to type 2 diabetes. J Human Genet. 2013;58:135-41.